Open Access

Notch pathway inhibitor DAPT accelerates in vitro proliferation and adipogenesis in infantile hemangioma stem cells

  • Authors:
    • Xing Xu
    • Yao Wu
    • Honghong Li
    • Juan Xie
    • Dongsheng Cao
    • Xueying Huang
  • View Affiliations

  • Published online on: October 26, 2021     https://doi.org/10.3892/ol.2021.13115
  • Article Number: 854
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The Notch signaling pathway is crucial in both adipogenesis and tumor development. It serves a vital role in the development and stability of blood vessels and may be involved in the proliferative phase of infantile hemangiomas, which express various related receptors. Therefore, it was hypothesized that the Notch signaling pathway inhibitor N‑[N-(3,5‑difluorophenacetyl)‑L‑alanyl]‑S‑phenylglycine t‑butyl ester (DAPT), a γ‑secretase inhibitor, might help accelerate the regression of infantile hemangiomas. The present in vitro study evaluated whether inhibition of the Notch signaling pathway using DAPT could alter adipogenesis in hemangioma stem cells (HemSCs) derived from infantile hemangioma (IH) specimens. A total of 20 infants (age, ≤6 months) with hemangiomas who had not yet received any treatment were selected, and their discarded hemangioma tissues were obtained. HemSCs were isolated from the fresh, sterile IH specimens and treated with DAPT. Reverse transcription‑quantitative PCR and western blotting were used to demonstrate the inhibition of the Notch signaling pathway by DAPT. A proliferation assay (Cell Counting Kit‑8), oil red O staining, flow cytometry and a transwell assay were used to detect proliferation, adipogenesis, apoptosis and migration of HemSCs. Treatment with DAPT upregulated the expression levels of CCAAT/enhancer‑binding protein (C/EBP) α, C/EBPβ, peroxisome proliferator‑activated receptor‑γ, adiponectin and insulin‑like growth factor 1, and promoted the proliferation, apoptosis, migration and lipid accumulation in HemSCs in vitro. Targeting the Notch signaling pathway using DAPT may potentially accelerate the regression of infantile hemangiomas.
View References

Related Articles

Journal Cover

December-2021
Volume 22 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu X, Wu Y, Li H, Xie J, Cao D and Huang X: Notch pathway inhibitor DAPT accelerates <em>in vitro</em> proliferation and adipogenesis in infantile hemangioma stem cells. Oncol Lett 22: 854, 2021
APA
Xu, X., Wu, Y., Li, H., Xie, J., Cao, D., & Huang, X. (2021). Notch pathway inhibitor DAPT accelerates <em>in vitro</em> proliferation and adipogenesis in infantile hemangioma stem cells. Oncology Letters, 22, 854. https://doi.org/10.3892/ol.2021.13115
MLA
Xu, X., Wu, Y., Li, H., Xie, J., Cao, D., Huang, X."Notch pathway inhibitor DAPT accelerates <em>in vitro</em> proliferation and adipogenesis in infantile hemangioma stem cells". Oncology Letters 22.6 (2021): 854.
Chicago
Xu, X., Wu, Y., Li, H., Xie, J., Cao, D., Huang, X."Notch pathway inhibitor DAPT accelerates <em>in vitro</em> proliferation and adipogenesis in infantile hemangioma stem cells". Oncology Letters 22, no. 6 (2021): 854. https://doi.org/10.3892/ol.2021.13115